Go Pro
NYSE:RBOT

Vicarious Surgical (RBOT) Stock Price, News & Analysis

Vicarious Surgical logo
$0.08 -0.01 (-6.96%)
As of 07/31/2026 03:58 PM Eastern

About Vicarious Surgical Stock (NYSE:RBOT)

Advanced

Key Stats

Today's Range
$0.07
$0.08
50-Day Range
$0.08
$0.99
52-Week Range
$0.07
$10.50
Volume
26,520 shs
Average Volume
72,815 shs
Market Capitalization
$542.85 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Reduce

Company Overview

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology. In addition to the robotic hardware and VR interface, Vicarious Surgical provides comprehensive training programs, service contracts and remote support tools to help hospitals and surgical centers integrate its system into existing clinical workflows. The company has conducted early-stage clinical evaluations under FDA investigational device exemptions and is pursuing full regulatory clearance in the United States, with plans to seek approvals in key international markets upon U.S. authorization.

Founded in 2014 and headquartered in Boston, Massachusetts, Vicarious Surgical was co-founded by Dr. Adam Sachs, who serves as chief executive officer, and Dr. Justin Ryan, who oversees technology development as chief technology officer. The leadership team combines expertise in robotic engineering, software development and minimally invasive surgery, supported by a board that includes experienced healthcare and medical device executives.

After completing preclinical and feasibility studies, the company went public through a merger with a special purpose acquisition company in late 2021 and trades on the New York Stock Exchange under the ticker RBOT. With a focus on expanding clinical evidence and scaling its commercial infrastructure, Vicarious Surgical aims to bring its VR-enhanced robotic platform into broader surgical practice in the years ahead.

AI Generated. May Contain Errors.

Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RBOT Stock News Headlines

SS Innovations names Sarah Romano as CFO
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Vicarious Surgical, Inc. Class A
See More Headlines

RBOT Stock Analysis - Frequently Asked Questions

Vicarious Surgical's stock was trading at $2.16 at the beginning of the year. Since then, RBOT stock has decreased by 96.5% and is now trading at $0.0762.

Vicarious Surgical Inc. (NYSE:RBOT) issued its earnings results on Monday, March, 9th. The company reported ($1.65) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.37) by $0.28.

Vicarious Surgical shares reverse split on Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Aktis Oncology (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI).

Company Calendar

Last Earnings
3/09/2026
Today
8/01/2026
Next Earnings (Estimated)
8/06/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:RBOT
CIK
1812173
Fax
N/A
Employees
210
Year Founded
2014

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+9,086.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($6.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.22 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-184.13%
Return on Assets
-112.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.75
Quick Ratio
4.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.89 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
7,124,000
Free Float
5,894,000
Market Cap
$542.85 thousand
Optionable
No Data
Beta
1.88

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NYSE:RBOT) was last updated on 8/1/2026 by MarketBeat.com Staff.
From Our Partners